Wiki/Team:Warsaw/igem project.htm

From 2008.igem.org

Revision as of 21:52, 25 October 2008 by Emilia (Talk | contribs)

Gallery Bricks Notebook Team Project Home

Our Plans

First we want to note that our initial plans were very different from what we actually managed to do. Our plans were really amazing: we wanted to create system of biological machines which would allow to investigate protein interactions and simultaneously change sequence of one of them in order to achieve the strongest possible interaction. To make it work we planned to put the DNA sequence of tested protein on low-copy plasmid and transform it to bacterial strain in which it would be mutated (lets call the strain ‘one-armed bandit’). Parts present on this plasmid would cause the protein to be attached to outer bacterial membrane, where the selection would occur. We planned that such selection system would allow us to search for antibodies with new specificities or screen protein libraries.

‘The one-armed bandit’

1. The idea

Our goal is to change protein sequence in order to maximize its interaction with a given partner. Additionally we want to apply selection pressure on bacteria population so that only cells coding strongest interacting proteins survive. Solution for the first part of the problem is ‘the one-armed bandit’ strain, which will randomize target protein sequence – nucleotides would be shuffled randomly in the same way it happens in popular hazard game. The simplest ‘one-armed bandit’ strain is one of standard mutator E. coli strains without polymerase error correction activity or strain without DNA repair systems. It’s not optimal though - high mutation frequency in the whole bacterial genome would introduce some variance into our sequence, but would also cause problems with selection. Instead of screening for protein interactions we would most likely obtain selection-resistant strain. So we wanted to narrow scope of mutations to a small well defined DNA fragment preferably carried on plasmid. Since at the beginning of our project we focused on antibodies the idea of using AID (Activation Induced Deaminase) protein came right away.

The AID protein is active in mammal lymphocytes, where it causes the somatic hypermutation – an increase of mutation level in antibody coding sequences. Moreover there is a publication [PMID:12097915] demonstrating AID activity in E. coli cells. But that wasn’t yet what we wanted because AID mutated all highly-transcribed E. coli genes. We needed to find a way to target it to a specific DNA region. AID prefers single-stranded DNA that appears in highly-transcribed loci. So we needed to make our DNA sequence a highly transcribed one (preferably achieve the highest transcription level in the cell). Adding T7 promoter to our sequence seemed to be the perfect solution. Unfortunately many genes that can make cells selection-resistant are highly transcribed. So we went a step forward and created fusion between AID and T7 phage polymerase. T7 polymerase traverses the DNA fragment containing T7 promoter and carries AID, which introduces mutations.

AID is a small protein and its closest homologues form oligomers. The information about AID’s ability to form complexes is inconsistent, so we needed to consider such possibility and we created molecular device containing both free AID and AID-T7 fusion. We hoped that AID-T7 fusion would recruit free AID to DNA sequence containing T7 promoter. To sum up we have created following molecular devices on pMPMT5omega plasmid under arabinose promoter:

  1. AID

  2. AID in translation fusion with T7 phage polymerase

  3. AID in transcription fusion with T7 phage polymerase

  4. AID in transcription fusion with AID-T7 translation fusion

To test various variants of AID we needed proper reporter system. We have used alpha-complementing beta-galactosidase fragment under control of T7 promoter. It was cloned to one-copy plasmid pZC320 (minireplicon of plasmid F). After obtaining and induction of cotransformants carrying one of AID devices and reporter plasmid, we hoped to get some white colonies on X-gal plates, indicating mutated clones.

Fig. 1. Our reporter system for checking site-specificity of AID-induced mutations
pBAD - arabinose promoter; pT7 - T7 promoter; L - linker; RBS - sequence coding Ribosomal Binding Site; TAXI=LB+Tetracycline+Ampicillin+IPTG+X-gal

Simultaneously we carried out the rifampicin test (plated liquid cultures of tested strains on plates containing 300 μg/mL rifampicin) to check mutation level in whole genome of tested strains.

Fig. 2. Rifampicin test to check mutation level in bacteria expressing variants of AID.

2. Results

We have obtained various numbers of white clones using different AID encoding devices but sequencing of beta-galactosidase gene from those clones revealed no mutations. It has to be a flaw in our reporter system. It seems that expressed beta-galactosidase fragment encoded on pZC320 plasmid is somehow switched off. We have sequenced large fragments of many white clones of pZC320 – no mutations, no clues. The test was carried out in two E. coli strains: Top10 and GM2163. The latter has damaged Dam and Dcm methyltransferases so DNA repair systems relying on their activity are unable to repair mismatches created by AID. The results obtained so far are presented in table below:

  TOP10 GM2163
Strain Conditions Mean number of cfu
on rifampicin
Experiments OD Number of experiments Number of cfu
on rifampicin
wt none 9.20 5 2.77 3 1
pMPM-AID none 9.80 5 2.49 3 4
pMPM-AID 0.1% Arabinose 77.00 5 2.33 3 47
pTRC-AID none 12.33 3 2.41 1 -
pTRC-AID 0.5 mM IPTG 49.00 3 1.98 1 -
pMPM-AID+T7 0.1% Arabinose 137.50 2 1.80 2 99
pMPM-AID+T7 none 6.50 2 2.40 2 2
pMPM-AIDT7 0.1% Arabinose 18.50 2 2.64 2 12
pMPM-AIDT7 none 17.50 2 2.39 2 9

It turns out that AID works as we meant it to, but we didn't manage to put its fusion with T7 polymerase to work. In the end we decided to use another strain with elevated mutation level - E. coli GM2163.

‘Hunter’ and ‘prey’

The idea

In former paragraphs we described our mechanism of introducing variation to protein coding sequence (let's call the protein ‘hunter’). Now it’s time to tell how we be screened created population of ‘hunter’ proteins. At a first glance the most elegant solution is something similar to two-hybrid system. But that requires putting both ‘hunter’ and ‘prey’ in the same cell of ‘one-armed bandit’, which creates risk of changing ‘prey’ sequence - something we don’t want to happen. So the ‘prey’ protein must be supplied from outside and allow only best ‘hunters’ to survive.

This forces ‘hunter’ protein to be attached to cell surface, so all hunter constructs have fragment of OmpA (outer membrane protein) fused with ‘hunter’ protein. In this way ‘hunter’ is presented on E. coli outer membrane, which allows it to interact with ‘prey’ added to liquid culture medium.

Fig. 3. Variants of the selection system using two parts of TEM-1 beta-lactamase (alpha and omega).

Selection pressure is needed to let survive only cells with the best interacting proteins. We have used TEM-1 beta-lactamase (protein responsible for resistance to beta-lactam antibiotics such as ampicillin) split into two complementing fragments: alpha and omega. Those fragments do not form active complexes spontaneously. Antibiotic resistance is achieved only when alpha and omega are in close proximity – i.e. when they are connected to two strongly interacting proteins. So ‘hunter’ protein connected with one beta-lactamase fragment will catch ‘prey’ protein connected to another and will allow survival of the cell in ampicillin containing medium. Cell line carrying the best hunter protein will have selection advantage over others.

Fig. 4. The selection system at work: 1. 'One-armed bandit' mutates hunter protein; 2. Expression of mutated hunters on the surface of bacteria; 3. Adding prey; 4. The best hunters survive.

In order to confirm that this system works we have chosen two small strongly interacting proteins A and Z. The A protein is the famous protein from Staphylococcus aureus which binds to constant fragments of IgG antibodies and has many uses in molecular biology. The Z protein is its artificially created close relative [PMID:15238637]. Apart from interacting with the A protein the Z protein has ability to form oligomers (this interaction is much weaker than with A though). We have created many variants of construct based on pACYC177 vector (low copy – 10 copies per cell) with IPTG-induced promoter. They contain OmpA fragment, A and Z proteins and beta-lactamase fragments in various combinations. The A protein consists of two nearly identical repeats (each one may interact with Z protein) so part of constructs contains truncated version of A protein (A delta). Lists of pACYC177 constructs:

OmpA_alphaOmpA_omega
OmpA_A_alphaOmpA_Z_alpha
OmpA_A_omegaOmpA_Z_omega
OmpA_omega_Adelta_alphaOmpA_omega_Adelta
OmpA_Adelta_alphaOmpA_Adelta_omega

The last pair of constructs contains Adelta sequence, an abridged version of the A protein, sufficient to interact with Z protein but free from sequence repetition prone to generate PCR products of different length. These constructs were primarily used for mutagenesis.

The second group of constructs is used for overexpression and purification of ‘prey’. For this purpose we used pET15b vector with N-terminally His-tagged prey proteins. We have created:

His+A+omegaHis+Z+omega
His+OmpA-alphaHis+OmpA-omega
His+A-alphaHis+Z-alpha

The first two constructs were successfully used for overexpression and purification of prey proteins. Use of His-tags and NiNTA beads was not needed because of Z protein oligomerization resulting in the fact that 90% of the protein was present in post-sonication debris.

Table 2. Results of testing various hunter/prey combinations
(ampicillin concentration 50-75 μg/mL).
1) Growth decreased twofold.

Prey:Hunter:
OmpA_AlphaOmpA_omegaOmpa_A_AlphaOmpa_A_omegaOmpA_Z_AlphaOmpa_Z_Omega
His_Z_alphaCell deathCell survival1)Cell deathCell survivalCell deathCell survival
His_Z_omegaCell survival1)Cell deathCell survivalCell deathCell survivalCell death
No prey
Cell death

Our long-term plan is to replace A and Z proteins with antibody fragments and antigen but for now we need to check if it's working. To sequence the A protein we will introduce mutations which will make interaction with Z impossible. We will introduce constructs carrying mutated A sequences to ‘one-armed bandit’ strain – we want to check if and when reversion to wild type A will occur in mutant mixture. The simplest version of this experiment – mixing of two existing strains, isolating plasmid DNA and assessing strain proportions using restriction digests gave very promising results. After mixing equal amounts of OmpA_alpha and OmpA_A_alpha and using our selection system we have isolated only plasmid carrying OmpA_A_alpha (this experiment was also successful for mixture of OmpA_omega and OmpA_A_omega).

Further results and comments will be introduced in real-time. Stay in touch ;-)